MedTrace Logo

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

NCT03496402 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-03-18

No results posted yet for this study

Summary

Methodology:

Prospective, multicentric, open, non-randomised, non-therapeutic, interventional study

Conditions

Interventions

OTHER

Sampling on blood, bone marrow and cerebrospinal fluid

biological sampling during treatment and follow-up

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Gudrun SCHLEIERMACHER, MD · Institut Curie

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-20
Primary Completion
2027-04-19
Completion
2027-08-19

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03496402 on ClinicalTrials.gov